# A Bioequivalence Study of Three, 2 mg Nicotine Chewing Gums (Two Tests and One Reference) in Healthy Adult Smokers

> **NCT02688374** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 45 (actual)

## Conditions studied

- Tobacco Use Disorder

## Interventions

- **OTHER:** Treatment A: Nicorette 2 mg coated mint gum
- **OTHER:** Treatment B: Nicotinell 2 mg coated mint gum
- **OTHER:** Treatment C: Nicotinell 2 mg coated fruit flavor gum

## Key facts

- **NCT ID:** NCT02688374
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-11
- **Primary completion:** 2016-06-12
- **Final completion:** 2016-06-12
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2017-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02688374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02688374, "A Bioequivalence Study of Three, 2 mg Nicotine Chewing Gums (Two Tests and One Reference) in Healthy Adult Smokers". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT02688374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*